Search Results

Displaying Results 1-2 of 2 "'GLSI'"
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

Jan 30, 2026, 10:36 ET $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium

(NASDAQ: ONCY), AbbVie (NYSE: ABBV), Genmab (NASDAQ: GMAB), ADC Therapeutics (NYSE: ADCT), and Greenwich LifeSciences (NASDAQ: GLSI). 

More news about: Equity Insider

How $594B in Precision Tech is Cracking the Metastatic Cancer Code

Jan 07, 2026, 10:32 ET How $594B in Precision Tech is Cracking the Metastatic Cancer Code

LifeSciences, Inc. (NASDAQ: GLSI) provided updates on its Phase III FLAMINGO-01 trial evaluating GLSI-100 to prevent breast cancer recurrences,

More news about: USA News Group

Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.